Ingrid Hedenfalk
11 – 20 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
Gunnarsdottir, Frida Björk LU ; Briem, Oscar LU
; Lindgren, Aida Yifter
LU
; Källberg, Eva
LU
; Andersen, Cajsa
; Grenthe, Robert
; Rosenqvist, Cassandra
; Rydberg Millrud, Camilla
LU
; Wallgren, Mika
and Viklund, Hannah
, et al.
(2023)
In Frontiers in Immunology
14.
- Contribution to journal › Article
-
Mark
Deciphering the normal-like molecular subtype of breast cancer
Veerla, Srinivas LU
; Kimbung, Siker
LU
; Vallon-Christersson, Johan
LU
; Ebbesson, Anna
LU
and Hedenfalk, Ingrid
LU
(2023)
AACR Special Conference in Cancer Research: Advances in Breast Cancer Research
- Contribution to conference › Poster
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
Staaf, Johan LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
; Saal, Lao H
LU
; Kimbung, Siker
LU
; Hedenfalk, Ingrid
LU
; Lien, Tonje
; Sørlie, Therese
; Naume, Bjørn
and Russnes, Hege
, et al.
(2022)
In npj Breast Cancer
8.
p.1-17
- Contribution to journal › Article
-
Mark
How Reliable Are Gene Expression-Based and Immunohistochemical Biomarkers Assessed on a Core-Needle Biopsy? A Study of Paired Core-Needle Biopsies and Surgical Specimens in Early Breast Cancer
Saghir, Hani LU ; Veerla, Srinivas LU
; Malmberg, Martin
; Rydén, Lisa
LU
; Ehinger, Anna
LU
; Saal, Lao H.
LU
; Vallon-Christersson, Johan
LU
; Borg, Åke
LU
; Hegardt, Cecilia
LU
and Larsson, Christer
LU
, et al.
(2022)
In Cancers
14(16).
p.1-16
- Contribution to journal › Article
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Li, Minerva LU ; Måsbäck, Anna LU ; Malander, Susanne LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2022)
“FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”
- Contribution to conference › Poster
- 2021
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila LU ; Akrap, Nina LU ; Staaf, Johan LU
; Alves, Carla L
; Ehinger, Anna
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Beumers, Lukas
LU
; Veerla, Srinivas
LU
and Harbst, Katja
LU
, et al.
(2021)
In Breast cancer research : BCR
23(1).
p.26-26
- Contribution to journal › Article
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
Stenström, Jenny ; Hedenfalk, Ingrid LU
and Hagerling, Catharina
LU
(2021)
In Breast Cancer Research
23(1).
- Contribution to journal › Article
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
Jönsson, Jenny Maria LU ; Bååth, Maria LU ; Björnheden, Ida ; Sahin, Irem Durmaz LU ; Måsbäck, Anna LU and Hedenfalk, Ingrid LU
(2021)
In Cancers
13(2).
- Contribution to journal › Article
-
Mark
Detection of Copy Number Aberration and Tumor Fraction in Archival Cervical Specimens from Ovarian Cancer Patients using Shallow Whole Genome Sequencing.
Martin de la Fuente, Laura LU ; Li, Minerva LU ; Veerla, Srinivas LU
and Hedenfalk, Ingrid
LU
(2021)
- Contribution to conference › Poster
-
Mark
Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
- Contribution to journal › Article